Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
Titel:
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
Auteur:
Rugo, Hope S Bardia, Aditya Marmé, Frederik Cortés, Javier Schmid, Peter Loirat, Delphine Trédan, Olivier Ciruelos, Eva Dalenc, Florence Gómez Pardo, Patricia Jhaveri, Komal L Delaney, Rosemary Valdez, Theresa Wang, Hao Motwani, Monica Yoon, Oh Kyu Verret, Wendy Tolaney, Sara M
Verschenen in:
Lancet
Paginering:
Jaargang 402 () nr. 10411 pagina's 1423-1433
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license